Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isosorbide Dinitrate and Hydration for CIN Prevention
NCT02718521Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Mar 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of isosorbide dinitrate in contrast-induced nephropathy (CIN) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Incidence of Contrast Induced Nephropathy at 7 days. Status: unknown.
02
Drugs
isosorbide dinitrate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT02718521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02718521.